Associated Banc Corp Bristol Myers Squibb CO Transaction History

Associated Banc Corp

$3.64 Billion
Q3 2025

A detailed history of Associated Banc Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Associated Banc Corp holds 78,270 shares of BMY stock, worth $3.61 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

78,270

Previous 86,163 9.16%

Holding current value

$3.61 Million

Previous $3.99 Million 11.51%

% of portfolio

0.1%

Previous 0.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 24, 2025	SELL	$43.31 - $48.98 $341,845 - $386,599	-7,893 Reduced 9.16%	78,270 $3.53 Million
Q2 2025 Aug 12, 2025	SELL	$44.12 - $59.6 $965,742 - $1.3 Million	-21,889 Reduced 20.26%	86,163 $3.99 Million
Q1 2025 May 09, 2025	SELL	$53.9 - $63.11 $1.53 Million - $1.79 Million	-28,425 Reduced 20.83%	108,052 $6.59 Million
Q4 2024 Feb 10, 2025	SELL	$51.92 - $59.94 $638,979 - $737,681	-12,307 Reduced 8.27%	136,477 $7.72 Million
Q3 2024 Nov 13, 2024	SELL	$39.66 - $51.75 $558,531 - $728,795	-14,083 Reduced 8.65%	148,784 $7.7 Million
Q2 2024 Aug 01, 2024	SELL	$40.25 - $52.99 $291,369 - $383,594	-7,239 Reduced 4.26%	162,867 $6.76 Million
Q1 2024 May 09, 2024	SELL	$47.98 - $54.4 $371,413 - $421,110	-7,741 Reduced 4.35%	170,106 $9.22 Million
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $552,284 - $659,027	-11,392 Reduced 6.02%	177,847 $9.13 Million
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $52,622 - $58,839	909 Added 0.48%	189,239 $11 Million
Q2 2023 Aug 07, 2023	SELL	$63.71 - $70.74 $64,729 - $71,871	-1,016 Reduced 0.54%	188,330 $12 Million
Q1 2023 May 09, 2023	SELL	$65.71 - $74.53 $394 - $447	-6 Reduced -0.0%	189,346 $13.1 Million
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $112,512 - $133,230	1,643 Added 0.88%	189,352 $13.6 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $279 - $165,129	-2,149 Reduced 1.13%	187,709 $13.3 Million
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $550,314 - $606,088	-7,578 Reduced 3.84%	189,858 $14.6 Million
Q1 2022 May 11, 2022	SELL	$61.48 - $73.72 $589,470 - $706,827	-9,588 Reduced 4.63%	197,436 $14.4 Million
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $393,000 - $458,146	-7,328 Reduced 3.42%	207,024 $12.9 Million
Q3 2021 Nov 08, 2021	SELL	$59.17 - $69.31 $580,339 - $679,792	-9,808 Reduced 4.38%	214,352 $12.7 Million
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $1.78 Million - $1.94 Million	28,778 Added 14.73%	224,160 $15 Million
Q1 2021 May 05, 2021	SELL	$59.34 - $66.74 $3.76 Million - $4.23 Million	-63,400 Reduced 24.5%	195,382 $10.9 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $1.04 Million - $1.18 Million	18,038 Added 7.49%	258,782 $16.1 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $322,469 - $357,338	-5,615 Reduced 2.28%	240,744 $14.5 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $1.83 Million - $2.14 Million	33,342 Added 15.65%	246,359 $14.5 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $989,990 - $1.44 Million	21,336 Added 11.13%	213,017 $11.9 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $1.4 Million - $1.82 Million	28,410 Added 17.4%	191,681 $12.3 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $133,314 - $158,063	3,117 Added 1.95%	163,271 $8.28 Million
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $1.45 Million - $1.6 Million	32,453 Added 25.41%	160,154 $7.26 Million
Q1 2019 May 07, 2019	BUY	$45.12 - $53.8 $343,679 - $409,794	7,617 Added 6.34%	127,701 $6.09 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $199,330 - $258,484	-4,088 Reduced 3.29%	120,084 $6.24 Million
Q3 2018 Nov 07, 2018	SELL	$55.19 - $62.25 $86,372 - $97,421	-1,565 Reduced 1.24%	124,172 $7.71 Million
Q2 2018 Aug 07, 2018	BUY	$50.53 - $62.98 $6.35 Million - $7.92 Million	125,737 New	125,737 $6.96 Million

Others Institutions Holding BMY

# of Institutions

2,668

Shares Held

1.64B

Call Options Held

22.5M

Put Options Held

25.3M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $98B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

News

Stay updated on Associated Banc Corp with notifications on news.

Account

Associated Banc Corp Bristol Myers Squibb CO Transaction History